Catalpol and tetramethylpyrazine relieve Alzheimer's disease by facilitating AQP4 protein expression and polarized distribution in hippocampal astrocytes via inducing the STAT3-mediated UCHL1 expression
Naunyn-Schmiedeberg's Archives of Pharmacology · 2026
DOI: 10.1007/s00210-026-05435-1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, 2026. Verfasst von Chujun Deng und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Traditional Chinese Medicine, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, 600 Yish…. Hauptthemen laut MEDLINE: Ubiquitin Thiolesterase, Astrocytes, Hippocampus, Alzheimer Disease. Die Arbeit nennt 59 Literaturangaben. Gefördert von: Shanghai Sixth People's Hospital Medical Service Level Improvement Project Clinical Medical Technical Backbone Team Cultivation Project, Three-year Action Plan (2021-2023) of Shanghai Municipality for Further Accelerating the Inheritance, Innovation, and Development of Traditional Chinese Medici…, Construction of East China Area and Municipal TCM Specialist Disease Alliance.
Themen: Demenz
Abstract (Originalsprache)
Alzheimer's disease (AD) is a prevalent neurodegenerative disorder leading to dementia. This study investigated the effects of catalpol and tetramethylpyrazine (CT) on AD. AD mice were treated with CT, TGN020, 6RK73, and Stattic. The Morris water maze task was employed to assess spatial learning and memory. Histological staining was used to evaluate hippocampal neuronal damage, Aβ1-40 clearance, and AQP4 protein distribution in the hippocampus. An AD cell model was established by inducing Aβ1-42 in mouse astrocytes, followed by CT, 6RK73, and Stattic treatments. UCHL1 siRNA was transfected into astrocytes, and ubiquitination analysis was conducted. Gene expression was assessed via qRT-PCR and Western blot. CT improved spatial learning and memory in AD mice, mitigated hippocampal neuronal damage, enhanced Aβ1-40 clearance, increased UCHL1 and p-STAT3/STAT3 expression, and promoted AQP4 protein expression and its polarized distribution in the hippocampus. The improvement in spatial learning, memory, and hippocampal neuronal damage was diminished by TGN020. 6RK73 inhibited CT-induced AQP4 expression and its polarized distribution in hippocampal astrocytes. Stattic counteracted CT-induced upregulation of UCHL1 in the hippocampus. UCHL1 facilitated AQP4 deubiquitination. Silencing UCHL1 or treating with 6RK73 blocked CT-induced AQP4 expression and its polarized distribution in Aβ1-42-treated astrocytes. Stattic abolished CT-induced UCHL1 expression in Aβ1-42-treated astrocytes. CT likely promotes STAT3 phosphorylation, enhancing UCHL1 expression, which in turn facilitates AQP4 expression and its polarized distribution in hippocampal astrocytes, providing therapeutic benefits in AD. These findings suggest CT as a potential therapeutic agent for AD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Traditional Chinese Medicine, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, 600 Yishan Road, Xuhui District, Shanghai, 200030, China.
- Graduate School, Jiangxi University of Traditional Chinese Medicine, Jiangxi, China.
- School of Chemistry and Molecular Engineering, East China University of Science and Technology, Shanghai, China.
- Department of Traditional Chinese Medicine, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, 600 Yishan Road, Xuhui District, Shanghai, 200030, China. mengsx163@163.com.
Förderung
- Shanghai Sixth People's Hospital Medical Service Level Improvement Project Clinical Medical Technical Backbone Team Cultivation Project
- Three-year Action Plan (2021-2023) of Shanghai Municipality for Further Accelerating the Inheritance, Innovation, and Development of Traditional Chinese Medici…
- Construction of East China Area and Municipal TCM Specialist Disease Alliance
Zitieren
APA
Deng, C., Zhu, M., Yuan, J., Yin, T., Chen, H., & Meng, S. (2026). Catalpol and tetramethylpyrazine relieve Alzheimer's disease by facilitating AQP4 protein expression and polarized distribution in hippocampal astrocytes via inducing the STAT3-mediated UCHL1 expression. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-026-05435-1
Vancouver
Deng C, Zhu M, Yuan J, Yin T, Chen H, Meng S. Catalpol and tetramethylpyrazine relieve Alzheimer's disease by facilitating AQP4 protein expression and polarized distribution in hippocampal astrocytes via inducing the STAT3-mediated UCHL1 expression. Naunyn-Schmiedeberg's Archives of Pharmacology. 2026. doi:10.1007/s00210-026-05435-1
BibTeX
@article{Deng2026,
author = {Deng, Chujun and Zhu, Mengting and Yuan, Jing and Yin, Tianxiang and Chen, Huize and Meng, Shengxi},
title = {Catalpol and tetramethylpyrazine relieve Alzheimer's disease by facilitating AQP4 protein expression and polarized distribution in hippocampal astrocytes via inducing the STAT3-mediated UCHL1 expression},
journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
year = {2026},
doi = {10.1007/s00210-026-05435-1}
}
EUVIMED